Page last updated: 2024-08-25

tebuconazole and Plague

tebuconazole has been researched along with Plague in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alldredge, MW; Bevins, SN; Boyce, WM; Boydston, EE; Crooks, KR; Fisher, RN; Franklin, SP; Gage, KL; Krumm, C; Logan, KA; Lyren, LM; Macmillan, ML; Riley, SP; Roelke, ME; Salman, M; Schmit, VL; Schriefer, ME; Sweanor, LL; Tracey, JA; Vandewoude, S; Vickers, W1
Powell, B; Rocke, TE; Shenk, TM; Wolfe, LL1
Shenk, TM; Spraker, TR; Wild, MA1

Other Studies

3 other study(ies) available for tebuconazole and Plague

ArticleYear
Wild felids as hosts for human plague, Western United States.
    Emerging infectious diseases, 2009, Volume: 15, Issue:12

    Topics: Animals; Antibodies, Bacterial; Colorado; Disease Reservoirs; Humans; Lynx; Plague; Puma; Seroepidemiologic Studies; Yersinia pestis

2009
Assessment of a recombinant F1-V fusion protein vaccine intended to protect Canada lynx (Lynx canadensis) from plague.
    Journal of wildlife diseases, 2011, Volume: 47, Issue:4

    Topics: Animals; Antibodies, Bacterial; Case-Control Studies; Conservation of Natural Resources; Female; Lynx; Plague; Plague Vaccine; Recombinant Fusion Proteins; Vaccines, Synthetic; Yersinia pestis

2011
Plague as a mortality factor in Canada lynx (Lynx canadensis) reintroduced to Colorado.
    Journal of wildlife diseases, 2006, Volume: 42, Issue:3

    Topics: Animals; Colorado; Conservation of Natural Resources; Female; Fluorescent Antibody Technique; Lynx; Plague; Yersinia pestis

2006